Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Alphabets quarterly report and outlook triggered a sharp selloff as earnings and search/ad results disappointed, while strong Google Cloud growth was overshadowed by heavy AI infrastructure spending and concern about cash flow. Traders are split between viewing the drop as an overreaction and buying opportunity and worrying that rising investment may take time to deliver returns.

Alphabets earnings miss and concerns about heavy AI spending, cash burn, and slower search and advertising growth are driving the discussion, despite strong Google Cloud growth. Traders are split between fearing that AI costs and competition threaten the business and viewing the selloff as an overreaction and a buying opportunity.

ServiceNows quarterly report triggered a sharp selloff: revenue and AI momentum were strong, but an earnings-per-share miss and slower expected growth in contracted revenue raised concerns about growth and valuation. Traders are divided between calling the reaction an overreaction and buying the dip, and arguing that the softer forward bookings outlook warrants a reset.

Microsofts quarterly results beat expectations, with accelerating Azure growth and lower-than-expected capital spending driving an initially bullish reaction. Traders debated whether the strong cloud performance outweighed concerns about cash flow and future AI returns, while the shares gains faded amid broader tech weakness and comparisons with Alphabets results.

Oracles investor-day outlook for strong long-term revenue and free-cash-flow growth, with capital spending expected to peak and financing needs constrained, eased concerns about funding its AI data-center buildout and sparked a sharp rally. Traders welcomed the guidance and discussed a possible short squeeze, while skeptics questioned whether the projections are achievable and pointed to profit-taking and a pullback after the surge.

Speculation that Marvell is in advanced talks to acquire Lumentum (LITE) is driving attention, with traders questioning the deals cost and impact on Marvell shareholders. Others see potential AI-photonics and optical-networking synergies, while noting the reports are unverified.

Fortinets quarterly results sparked a sharp selloff despite beating earnings and revenue estimates and raising its outlook. Traders debate whether the reaction reflects high expectations and concerns about margins or the defensive tone on the call, while others call the drop excessive and see a buying opportunity.

Vikings Q3 update and conference call have focused attention on VK2735s obesity-trial progress and positive maintenance results, while renewed concerns about cash burn, dilution and the lack of clarity on a partnership or commercialization strategy have weighed on sentiment. The community is split between criticism of management and the recent share-price decline, and optimism that the pipeline could gain value as Phase 3 data approaches.

Reports that Marvell is in advanced talks to acquire Lumentum have sparked the move, with traders weighing potential synergies against concerns about financing and deal terms. The acquisition remains unconfirmed, and some community members question why LITE is rising while MRVL falls.

Sellass Phase 3 REGAL AML trial reached its prespecified 80th event, triggering final analysis ahead of topline results; the milestone did not disclose whether the trial met its endpoint. The sharp selloff prompted debate, with some traders calling it a sell-the-news overreaction and others stressing the unresolved binary risk of the upcoming data readout.